The National Walk To End Brain Tumors raised over $230,000 this month for the Musella Foundation to use for research. We awarded $210,000 this round and will save the remaining $20,000 to use with the next round of grants. These events were run by individuals who are committed to helping speed up the search for the cure. None of them had prior experience! They all did a fantastic job. If you would like to host a fundraiser for us, just contact me at musella@aol.com
Novocure Announces First Analysis of Full 700 Patient Dataset from Successful Newly Diagnosed GBM Phase III Trial This confirms the good results they reported in the interim analysis a few months ago. 2 year survival for newly diagnosed GBM patients went up from 29% in the standard therapy group to 43% in the standard + Novocure group. More of the details will come out on June 2, 2015. When I discussed the interim results with neuro-oncs , many took the cautious viewpoint of "wait for the full results - it can't be that good". Well - these are the full results and almost as good as the interim results. They also had concern that perhaps a major difference in prognostic factors between the control group and treatment group might account for the difference. Hopefully we will find out in a few days when more details are released.
